Metabolomics reveals metabolic biomarkers of Crohn's disease
The causes and etiology of Crohn's disease (CD) are currently unknown although both host genetics and environmental factors play a role. Here we used non-targeted metabolic profiling to determine the contribution of metabolites produced by the gut microbiota towards disease status of the host. Ion Cyclotron Resonance Fourier Transform Mass Spectrometry (ICR-FT/MS) was used to discern the masses of thousands of metabolites in fecal samples collected from 17 identical twin pairs, including healthy individuals and those with CD. Pathways with differentiating metabolites included those involved in the metabolism and or synthesis of amino acids, fatty acids, bile acids and arachidonic acid. Several metabolites were positively or negatively correlated to the disease phenotype and to specific microbes previously characterized in the same samples. Our data reveal novel differentiating metabolites for CD that may provide diagnostic biomarkers and/or monitoring tools as well as insight into potential targets for disease therapy and prevention.
- Research Organization:
- Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)
- Sponsoring Organization:
- Earth Sciences Division
- DOE Contract Number:
- DE-AC02-05CH11231
- OSTI ID:
- 964377
- Report Number(s):
- LBNL-2153E; TRN: US200919%%224
- Journal Information:
- PLoS, Vol. 4, Issue 7; Related Information: Journal Publication Date: 2009
- Country of Publication:
- United States
- Language:
- English
Similar Records
Molecular analysis of the gut microbiota of identical twins with Crohn's disease
Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease